-
Home
-
Product
-
IMMUNOHISTOCHEMISTRY
-
INSTRUMENT
-
MOLECULAR
-
HISTOLOGY
-
CYTOLOGY
-
DIGITAL PATHOLOGY
-
-
Solution
-
Support
-
About
-
Contact
PRODUCT CATEGORY
CONTACT US
Phone
Email
Address
ZhengZhou (HQ), Shenzhen (R&D Center), Suzhou (R&D Center), China
PML/RARA Gene Fusion Detection Kit
Clinic Signification：
1.More than 95% of APL patients are associated with PML/RARA fusion genes, accounting for about 9% of all AML.
2.Mark for M3 classification and excellent prognosis.
3.Guiding the use of drugs, and the treatment of targeted drugs all-trans retinoic acid and arsenic trioxide and evaluation.
Chat
message
Quote
Contrast
PML/RARA Negative
PML/RARA Positive
More Info
Probe Description: PML/RARA
Cat.No.: CF1121
Specification: 10 tests/box, 20 tests/box
Related Product
